Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Eastern Company
EML
$154M
| $600K | ﹤0.01% |
33,585
-1,932
| -5% | -$35.3K |
|
3277
Funko
FNKO
$331M
| $599K | ﹤0.01% |
103,201
+6,077
| +6% | +$29.4K |
|
3278
ROBO Global Robotics & Automation Index ETF
ROBO
$2.13B
| $597K | ﹤0.01% |
13,731
-2,345
| -15% | -$93.2K |
|
|
HUD
3279
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $596K | ﹤0.01% |
122,272
-878
| -0.7% | -$4.58K |
|
3280
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.35B
| $594K | ﹤0.01% |
+9,500
| New | +$548K |
|
3281
Cedar Fair
FUN
$1.68B
| $593K | ﹤0.01% |
21,550
+1,549
| +8% | +$44.1K |
|
3282
Titan International
TWI
$438M
| $593K | ﹤0.01% |
406,159
-169,655
| -29% | -$228K |
|
|
WMC
3283
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $593K | ﹤0.01% |
21,647
+453
| +2% | +$11.6K |
|
3284
FirstService
FSV
$6.24B
| $591K | ﹤0.01% |
5,872
+300
| +5% | +$26.6K |
|
3285
CarParts.com
PRTS
$48.7M
| $591K | ﹤0.01% |
+6,831
| New | +$364K |
|
3286
ARK Innovation ETF
ARKK
$6.54B
| $589K | ﹤0.01% |
+8,256
| New | +$483K |
|
3287
Westwood Holdings Group
WHG
$183M
| $589K | ﹤0.01% |
37,380
-73,797
| -66% | -$1.4M |
|
|
NBSE
3288
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $584K | ﹤0.01% |
+3,323
| New | +$556K |
|
|
AGRX
3289
DELISTED
Agile Therapeutics
AGRX
| $584K | ﹤0.01% |
105
+77
| +275% | +$400K |
|
|
MSON
3290
DELISTED
Misonix Inc
MSON
| $584K | ﹤0.01% |
43,096
+19,392
| +82% | +$237K |
|
3291
Fulcrum Therapeutics
FULC
$283M
| $583K | ﹤0.01% |
31,914
-1,389
| -4% | -$21.9K |
|
3292
VanEck Agribusiness ETF
MOO
$972M
| $583K | ﹤0.01% |
9,696
| – | – |
|
3293
CorMedix
CRMD
$639M
| $582K | ﹤0.01% |
92,193
+2,306
| +3% | +$10.7K |
|
3294
Franklin Financial Services
FRAF
$289M
| $580K | ﹤0.01% |
22,443
+3,092
| +16% | +$79.9K |
|
3295
Alpha Pro Tech
APT
$54.8M
| $579K | ﹤0.01% |
+32,692
| New | +$451K |
|
|
HMTV
3296
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $574K | ﹤0.01% |
58,365
-1,358
| -2% | -$12.4K |
|
3297
Ring Energy
REI
$349M
| $573K | ﹤0.01% |
493,931
-221,776
| -31% | -$217K |
|
3298
Atomera
ATOM
$212M
| $572K | ﹤0.01% |
63,574
+32,723
| +106% | +$224K |
|
|
CHMA
3299
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $571K | ﹤0.01% |
106,148
+1,604
| +2% | +$8.83K |
|
3300
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $570K | ﹤0.01% |
167,676
+10,918
| +7% | +$34.4K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.